Application Objectives Delayed active-ingredient release serves several strategic purposes: Protection of acid-sensitive active ingredients (e.g., probiotics, enzymes) Reduction of gastric irritation (e.g., certain minerals) Targeted intestinal effect (e.g., microbiome modulation) Pharmacokinetic optimization In dietary supplements it is particularly important for maintaining the stability of probiotics, herbal extracts and bioactive peptides
CJC-1295 and Ipamorelin stimulate the body natural growth hormone release, which enhances tissue repair, muscle recovery, and fat metabolism
Avellina Aesthetics
Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, GHRP-2 vs Ipamorelin Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin At a glance BPC-157 half-life / approximately 4 hours (subcutaneous or intramuscular) TB-500 half-life / longer systemic distribution, dosed 2-4 mg twice weekly IGF-1 LR3 active window / up to 20 hours vs ~20 minutes for native IGF-1 Semax mechanism / upregulates BDNF and dopamine receptor sensitivity Selank mechanism / enhances GABA-A tone and reduces IL-6 by ~30% in animal models GHRP-2 GH pulse / strong but co-elevates cortisol and prolactin Ipamorelin GH pulse / selective
Fat slows gastric emptying further, compounding the effect
Treatment for Insomnia Even though many women and men rely on over-the-counter melatonin supplements to help them sleep, hormone replacement therapy, such as estrogen replacement therapy, is a more effective treatment for insomnia related to a hormonal imbalance